| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |